Literature DB >> 6774042

Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene.

W L Griffing, S B Moore, H S Luthra, C H McKenna, C G Fathman.   

Abstract

We examined the incidence of B lymphocyte (HLA-DRw) alloantigens in patients who exhibited elevated antibody titers to native DNA irrespective of their diagnosis. We found a statistically significant (P less than or equal to 0.0001) association between HLA-DRw3 and the presence of antibodies to native DNA not only in patients with a diagnosis of systemic lupus erythematosus but in other patients who did not share that diagnosis. This association supports the existence of a human immune response gene linked to the HLA complex. These data suggest that the hypothesis of an association between HLA and disease operating through disease susceptibility antigens or genes might be invalid and supports an alternative hypothesis, that HLA and disease associations are a manifestation of an immune response gene that controls the production of specific antibodies in any of several disease states.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774042

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Immunogenetic markers in rheumatic diseases.

Authors:  L Martin; M J Fritzler
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

3.  MHC class I polymorphism in lupus-prone MRL/Mp mice.

Authors:  S L Peng; J Craft
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis.

Authors:  J P Pandey; J M Goust; J P Salier; H H Fudenberg
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.

Authors:  D L Mann; N Mendell; C R Kahn; A H Johnson; A Rosenthal
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man.

Authors:  A M Solinger; R Bhatnagar; J D Stobo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

7.  Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf alleles.

Authors:  R S Warlow; G Uko; J McCluskey; P H Kay; F T Christiansen; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

8.  Immune phenotype of chronic liver disease.

Authors:  A J Czaja; R M dos Santos; A Porto; P J Santrach; S B Moore
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

9.  DNA typing of HLA-DR antigens in systemic lupus erythematosus.

Authors:  H Dunckley; P A Gatenby; S W Serjeantson
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 10.  Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus.

Authors:  Manfred Relle; Andreas Schwarting
Journal:  Clin Dev Immunol       Date:  2012-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.